Abstract
The aim of this pharmacokinetic analysis was to develop and validate a population pharmacokinetic model for R‐ and S‐ibuprofen from samples obtained after 3 successive administrations of ibuprofen (10–5–5 mg/kg) at 24‐hour intervals to preterm newborn infants aged from 1/2) of 34.3 hours for S‐ibuprofen. Estimated clearance at birth and volume of distribution were 25.5 mL/h/kg and 306 mL/kg with a t1/2 at birth of 8.3 hours for R‐ibuprofen. R‐ibuprofen elimination increased during the first week of life, whereas S‐ibuprofen pharmacokinetics were weakly modified. Therefore, because the activity of the 2 enantiomers differs, it is important that subsequent studies consider R‐ and S‐enantiomers separately. Mean simulated ibuprofen concentrations at various dose regimens were in agreement with observed concentrations. The present analysis allows a more accurate estimation of the ibuprofen pharmacokinetics as parameters could be estimated separately for each enantiomer and the effect of postnatal age on the elimination of R‐ibuprofen was elicited.

This publication has 22 references indexed in Scilit: